Usage instructions NAD+ Injections are self-injected 1-3 times per week, with or without food, according to your provider-guided titration schedule
These weight-loss measurements are lower than those recorded for other GLP-1 drugs, such as semaglutide, which are reported to result in mean weight reductions of 1520% and beyond
Instead, aim for four to six small meals throughout the day, each containing 200300 calories
Ethics declarations Ethics approval and consent to participate No animal or tissue culture work was carried out in the study
Also see: Do any supplements help with COVID-19
Retatrutide's glucagon component introduces an additional monitoring consideration: transient increases in fasting plasma glucose have been observed, particularly during dose escalation at 12 mg